Detalhe da pesquisa
1.
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 387(17): 1557-1568, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094839
2.
Combined BRAF, MEK, and heat-shock protein 90 inhibition in advanced BRAF V600-mutant melanoma.
Cancer
; 130(2): 232-243, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776537
3.
Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.
J Neurooncol
; 166(3): 431-440, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310157
4.
Patient reported outcomes and patient experiences of immune checkpoint modulators for advanced or recurrent melanoma: a mixed methods study.
Support Care Cancer
; 32(6): 330, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709312
5.
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Lancet Oncol
; 24(11): 1196-1205, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875144
6.
Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients.
Cancer
; 129(11): 1723-1734, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869646
7.
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.
Lancet
; 400(10357): 1008-1019, 2022 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108657
8.
Current and future approaches in the surgical management of T3b/T4 primary and locoregionally advanced melanoma.
Cancer
; 128(21): 3764-3771, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36066835
9.
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
J Transl Med
; 20(1): 200, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538491
10.
PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence.
Future Oncol
; 18(8): 903-913, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35073733
11.
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Lancet Oncol
; 22(12): 1692-1704, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774225
12.
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
N Engl J Med
; 379(8): 722-730, 2018 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30134131
13.
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 379(4): 341-351, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29863979
14.
Assessing the Value of Cemiplimab for Adults With Advanced Cutaneous Squamous Cell Carcinoma: A Cost-Effectiveness Analysis.
Value Health
; 24(3): 377-387, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33641772
15.
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
Lancet Oncol
; 21(2): 294-305, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952975
16.
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 21(11): 1465-1477, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961119
17.
Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design.
Future Oncol
; 16(28): 2165-2175, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723187
18.
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.
Future Oncol
; 16(4): 11-19, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31951149
19.
Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy.
World J Surg
; 44(4): 1283-1293, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811340
20.
Management of intussusception in patients with melanoma.
J Surg Oncol
; 119(7): 897-902, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30734297